CLINICAL_TRIALS
trial_result
· 2011-03-23
Clinical Trial Update: Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia [Phase 2]
Summary
A Phase 2 pilot trial evaluated levodopa as a treatment for residual amblyopia, with results posted in 2011.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Jaeb Center for Health Research | Conditions: Amblyopia | Phase 2 | Status: COMPLETED | Results posted: 2011-03-23